0
0
Biopharma company BioNTech is advocating for a possible booster vaccination with its existing vaccine.
“We think at the moment it is best to proceed with a booster dose for the existing virus strain to get the situation under control,” company CEO Ugur Sahin said Monday.
Patients who received a third dose of the same vaccine showed significantly higher antibody levels than after the second dose, he said.
It is not clear which virus variants might emerge in the coming months, Sahin explained. Therefore, it does not make sense to adjust the vaccine now.
Significant jump in profits for BioNTech
The success of its Corona vaccine has given German company BioNTech a huge jump in sales and profits. The company said Monday that net profit in the second quarter of 2021 rose to nearly 2.8 billion euros, compared with a loss of 88.3 million euros in the same period last year. For the first six months of this year, net income was just over 3.9 billion euros, compared with a loss of almost 142 million euros a year earlier.
- source: k.at/picture: pixabay.com
This post has already been read 564 times!
